Literature DB >> 6164426

Angiotensin converting enzyme inhibition: a new therapeutic modality.

H Gavras, F Charocopos, H Brunner, I Gavras.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6164426      PMCID： PMC1805226     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN： 0028-7091


× No keyword cloud information.
  18 in total

1.  Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man.

Authors:  H Gavras; H R Brunner; G A Turini; G R Kershaw; C P Tifft; S Cuttelod; I Gavras; R A Vukovich; D N McKinstry
Journal:  N Engl J Med       Date:  1978-05-04       Impact factor: 91.245

2.  Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients.

Authors:  H R Brunner; H Gavras; B Waeber; G R Kershaw; G A Turini; R A Vukovich; D N McKinstry; I Gavras
Journal:  Ann Intern Med       Date:  1979-01       Impact factor: 25.391

3.  Treatment of chronic congestive heart failure with captopril, an oral inhibitor of angiotensin-converting enzyme.

Authors:  R Davis; H S Ribner; E Keung; E H Sonnenblick; T H LeJemtel
Journal:  N Engl J Med       Date:  1979-07-19       Impact factor: 91.245

4.  Increased glomerular filtration rate after converting-enzyme inhibition in essential hypertension.

Authors:  N K Hollenberg; S L Swartz; D R Passan; G H Williams
Journal:  N Engl J Med       Date:  1979-07-05       Impact factor: 91.245

5.  Angiotensin II inhibition. Treatment of congestive cardiac failure in a high-renin hypertension.

Authors:  H Gavras; A Flessas; T J Ryan; H R Brunner; D P Faxon; I Gavras
Journal:  JAMA       Date:  1977-08-22       Impact factor: 56.272

6.  Angiotensin converting enzyme inhibition in patients with congestive heart failure.

Authors:  H Gavras; D P Faxon; J Berkoben; H R Brunner; T J Ryan
Journal:  Circulation       Date:  1978-11       Impact factor: 29.690

7.  Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure.

Authors:  C Curtiss; J N Cohn; T Vrobel; J A Franciosa
Journal:  Circulation       Date:  1978-11       Impact factor: 29.690

8.  Accentuated vascular and endocrine response to SQ 20881 in hypertension.

Authors:  G H Williams; N K Hollenberg
Journal:  N Engl J Med       Date:  1977-07-28       Impact factor: 91.245

9.  Converting enzyme inhibition in hypertensive emergencies.

Authors:  C P Tifft; H Gavras; G R Kershaw; I Gavras; H R Brunner; C S Liang; A V Chobanian
Journal:  Ann Intern Med       Date:  1979-01       Impact factor: 25.391

10.  Innappropriate renin secretion unmasked by captopril (SQ 14 225) in hypertension of chronic renal failure.

Authors:  H R Brunner; B Waeber; J P Wauters; G Turin; D McKinstry; H Gavras
Journal:  Lancet       Date:  1978-09-30       Impact factor: 79.321
View more
  1 in total

1.  Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.

Authors:  S Ricci; P Zaniol; V Teglio; P Baraldi; G Mattioli
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.